Silvia Cernea Clark

Rice scientists’ custom, large-scale neurorecording array sheds light on how the brain keeps the world looking familiar.

Rice researchers and collaborators developed a computational tool that can help identify which specific types of cells in the body are genetically linked to complex human traits and diseases, including in forms of dementia such as Alzheimer’s and

Rice bioengineers have designed an erasable serum marker that could enable clinicians to detect problems or measure any changes in how a patient responds to treatment with greater precision, using simple, minimally-invasive testing.

Rice scientists have developed the first complete, label-free molecular atlas of the Alzheimer’s brain in an animal model.

A new study reports first-time use of artificial intelligence for genetic circuit design.

Rice bioengineer Antonios Mikos is part of a team of researchers led by the Wake Forest Institute for Regenerative Medicine awarded up to $24.8 million over five years to help address the nation’s growing organ donor shortage by bioprinting

Researchers at Rice and collaborators have refined a DNA base-editing technology to make it more precise, a step that could improve prospects for treating some patients with cystic fibrosis.

Rice researchers and collaborators induced heart cells to increase mitochondria production to optimal levels, opening a path toward a new therapy for heart failure.

A technology designed to read gene activity in the brain from a simple blood test has now cleared a major translational hurdle.

A team of researchers led by Rice bioengineer Omid Veiseh has been awarded up to $18.2 million in funding from the Advanced Research Projects Agency for Health to develop a first-of-its-kind regenerative treatment aimed at restoring damaged